Vyne Therapeutics Inc
Biotechnology
Healthcare
VYNE
42.67 M shares
NASDAQ US
traded
29 Jul 2025
listed
no
open
1.47
52 week high
4.28
high
1.49
52 week low
0.00
previous Close
1.45
P/E ratio
market cap
23.75 M
div yield
0
net incoming
-8.61 M
28.37 %
net profit margin
-4262.87 %
10049.00 %
operating incoming
-9.20 M
27.98 %
net change in cash
8.28 M
129.64 %
cash on hand
28.21 M
41.57 %
top